Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

JAMA Neurology- United States

doi 10.1001/jamaneurol.2016.2032

Full Text

Abstract

Available in

Categories

Date

September 1, 2016

Authors

Elena Cortés-Vicente

Eduard Gallardo

María Ángeles Martínez

Jordi Díaz-Manera

Ricard Rojas-García

Publisher

American Medical Association (AMA)

Related search

Infantile Onset Myasthenia Gravis With MuSK Antibodies

Pediatric Neurology Briefs

English

Clinical Features and Quality of Life in Patients With Myasthenia Gravis

Journal of the Neurological Sciences

English

Circulating Regulatory Anti–T Cell Receptor Antibodies in Patients With Myasthenia Gravis

Journal of Clinical Investigation

English

Association of Ramadan Fasting and Clinical Outcomes in Patients With Myasthenia Gravis

JAMA network open

English

Anti-P110 Autoantibodies Identify a Subtype of “Seronegative” Myasthenia Gravis With Prominent Oculobulbar Involvement

Laboratory Investigation

Forensic Medicine

Molecular Biology

English

The Relationship of Plasma Levels of Pyridostigmine to Clinical Effect in Patients With Myasthenia Gravis

Journal of Neurology, Neurosurgery and Psychiatry

English

Antibodies to Striated Muscle and Acetylcholine Receptors in Evaluation of Surgical Treatment Outcomes in Patients With Autoimmune Myasthenia Gravis

Grekov's Bulletin of Surgery

English

Adverse Events Releated to Antibiotic Use in Patients With Myasthenia Gravis

Open Forum Infectious Diseases

English

Refractory Myasthenia Gravis: Clinical Description and Literature Review

Scholars Journal of Applied Medical Sciences

English